Clinical Trial Update: Efficacy of PegIntron (Peginterferon Alfa-2b) and Rebetol (Ribavirin) in Treatment-naïve Subjects With Chronic Hepatitis C in Clinical Practice in Greece (Study P05209)

View source ↗

Summary

Clinical trial update (NCT00724464) evaluating PegIntron (peginterferon alfa-2b) plus Rebetol (ribavirin) in treatment-naïve adults with chronic hepatitis C in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• PegIntron (pegylated interferon alfa-2b)
• Rebetol (ribavirin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic, Hepatitis C | Status: COMPLETED | Results posted: 2011-11-08